natgillin/translations-raw huggingface dataset:
Irbesartan Hydrochlorothiazide Winthrop indeholder hydrochlorthiazid og kan derfor ikke anbefales under graviditetens første trimester.
Since Irbesartan Hydrochlorothiazide Winthrop contains hydrochlorothiazide, it is not recommended during the first trimester of pregnancy.
35 Sygdomme i bevægeapparatet, bindevæv og knogler:
35
37 4. 9 Overdosering
37 The dose dependent adverse events of hydrochlorothiazide (particularly electrolyte disturbances) may increase when titrating the hydrochlorothiazide.
Kombinationen af hydrochlorthiazid og irbesartan giver en dosisrelateret additiv reduktion af blodtrykket over hele det terapeutiske dosisinterval for de enkelte lægemidler.
38 The combination of hydrochlorothiazide and irbesartan produces dose-related additive reductions in blood pressure across their therapeutic dose ranges.
38 med 300 mg irbesartan alene, medførte yderligere placebo- korrigeret diastolisk blodtryksreduktion ved laveste måling (24 timer efter dosis) på 6, 1 mmHg.
The addition of 12.5 mg hydrochlorothiazide to 300 mg irbesartan once daily in patients not adequately controlled on 300 mg irbesartan alone resulted in further placebo-corrected diastolic blood pressure reductions at trough (24 hours post-dosing) of 6.1 mm Hg.
Forholdet mellem den laveste og den maksimale effekt af Irbesartan Hydrochlorothiazide Winthrop 150 mg / 12, 5 mg var 100%, når blodtrykket blev monitoreret ambulant.
When measured by ambulatory blood pressure monitoring, the trough to peak effects of Irbesartan Hydrochlorothiazide Winthrop 150 mg/ 12.5 mg were 100%.
39 Det primære formål med forsøget var at sammenligne andelen af patienter hvis SeDBT var kontrolleret (SeDBT < 90 mmHg) ved Uge 5.
39 The primary objective of this study was to compare the proportion of patients whose SeDBP was controlled (SeDBP < 90 mmHg) at Week 5 of treatment.
Irbesartan fjernes ikke ved hæmodialyse.
40 haemodialysis.
41 Hydrochlorthiazid:
41 abortion or early resorption was noted at doses causing significant maternal toxicity, including mortality.
Irbesartan Hydrochlorothiazide Winthrop 300 mg/ 12, 5 mg filmovertrukne tabletter.
Irbesartan Hydrochlorothiazide Winthrop 300 mg/ 12.5 mg film-coated tablets.
44 Leverfunktionsnedsættelse:
44 Intravascular volume depletion: volume and/ or sodium depletion should be corrected prior to administration of Irbesartan Hydrochlorothiazide Winthrop.
47 farmakokinetik er ikke evalueret.
47 extent by glucuronidation.
Patienter, der planlægger at blive gravide, bør ændre til anden antihypertensiv behandling hvor sikkerhedsprofilen for anvendelse under graviditet er veletableret, medmindre fortsat behandling med AIIRAer skønnes nødvendig.
48 AIIRAs therapy is considered essential, patients planning pregnancy should be changed to alternative anti-hypertensive treatments which have an established safety profile for use in pregnancy.
49 Sygdomme i bevægeapparatet, bindevæv og knogler:
49
50
50 Irbesartan:
Bivirkninger (uanset relation til lægemidlet) rapporteret ved anvendelse af hydrochlorthiazid alene omfatter:
Adverse reactions reported with the use of irbesartan alone include:
Sygdomme i blod - og lymfesystemet:
General disorders and administration site conditions:
Aplastisk anæmi, knoglemarvsdepression, neutropeni/ agranulocytose, hæmolytisk anæmi, leukopeni, trombocytopeni
Uncommon:
Psykiske lidelser:
chest pain
Depression, søvnforstyrrelser
Hydrochlorothiazide:
Sygdomme i nervesystemet:
Psychiatric disorders: depression, sleep disturbances
51 4. 9 Overdosering
51 The dose dependent adverse events of hydrochlorothiazide (particularly electrolyte disturbances) may increase when titrating the hydrochlorothiazide.
Kombinationen af hydrochlorthiazid og irbesartan giver en dosisrelateret additiv reduktion af blodtrykket over hele det terapeutiske dosisinterval for de enkelte lægemidler.
52 The combination of hydrochlorothiazide and irbesartan produces dose-related additive reductions in blood pressure across their therapeutic dose ranges.
52 med 300 mg irbesartan alene, medførte yderligere placebo- korrigeret diastolisk blodtryksreduktion ved laveste måling (24 timer efter dosis) på 6, 1 mmHg.
The addition of 12.5 mg hydrochlorothiazide to 300 mg irbesartan once daily in patients not adequately controlled on 300 mg irbesartan alone resulted in further placebo-corrected diastolic blood pressure reductions at trough (24 hours post-dosing) of 6.1 mm Hg.
53 Det primære formål med forsøget var at sammenligne andelen af patienter hvis SeDBT var kontrolleret (SeDBT < 90 mmHg) ved Uge 5.
53 The primary objective of this study was to compare the proportion of patients whose SeDBP was controlled (SeDBP < 90 mmHg) at Week 5 of treatment.
Irbesartan fjernes ikke ved hæmodialyse.
Irbesartan is not removed by
54 Nedsat leverfunktion:
54 haemodialysis.
Irbesartans farmakokinetiske parametre ændres ikke væsentligt hos patienter med mild/ moderat cirrhose.
In patients with creatinine clearance < 20 ml/ min, the elimination half-life of hydrochlorothiazide was reported to increase to 21 hours.
Der er ikke foretaget undersøgelser af patienter med alvorligt nedsat leverfunktion.
Hepatic impairment: in patients with mild to moderate cirrhosis, the pharmacokinetic parameters of irbesartan are not significantly altered.
55 Hydrochlorthiazid:
55 abortion or early resorption was noted at doses causing significant maternal toxicity, including mortality.
Irbesartan Hydrochlorothiazide Winthrop 300 mg/ 25 mg filmovertrukne tabletter.
Irbesartan Hydrochlorothiazide Winthrop 300 mg/ 25 mg film-coated tablets.
58 Leverfunktionsnedsættelse:
58 Intravascular volume depletion: volume and/ or sodium depletion should be corrected prior to administration of Irbesartan Hydrochlorothiazide Winthrop.
61 farmakokinetik er ikke evalueret.
61 extent by glucuronidation.
Patienter, der planlægger at blive gravide, bør ændre til anden antihypertensiv behandling hvor sikkerhedsprofilen for anvendelse under graviditet er veletableret, medmindre fortsat behandling med AIIRAer skønnes nødvendig.
62 AIIRAs therapy is considered essential, patients planning pregnancy should be changed to alternative anti-hypertensive treatments which have an established safety profile for use in pregnancy.
63 Sygdomme i bevægeapparatet, bindevæv og knogler:
63
64
64 Irbesartan:
65 4. 9 Overdosering
65 The dose dependent adverse events of hydrochlorothiazide (particularly electrolyte disturbances) may increase when titrating the hydrochlorothiazide.
Kombinationen af hydrochlorthiazid og irbesartan giver en dosisrelateret additiv reduktion af blodtrykket over hele det terapeutiske dosisinterval for de enkelte lægemidler.
66 The combination of hydrochlorothiazide and irbesartan produces dose-related additive reductions in blood pressure across their therapeutic dose ranges.
66 med 300 mg irbesartan alene, medførte yderligere placebo- korrigeret diastolisk blodtryksreduktion ved laveste måling (24 timer efter dosis) på 6, 1 mmHg.
The addition of 12.5 mg hydrochlorothiazide to 300 mg irbesartan once daily in patients not adequately controlled on 300 mg irbesartan alone resulted in further placebo-corrected diastolic blood pressure reductions at trough (24 hours post-dosing) of 6.1 mm Hg.
67 Det primære formål med forsøget var at sammenligne andelen af patienter hvis SeDBT var kontrolleret (SeDBT < 90 mmHg) ved Uge 5.
67 The primary objective of this study was to compare the proportion of patients whose SeDBP was controlled (SeDBP < 90 mmHg) at Week 5 of treatment.
68 Nedsat leverfunktion:
68 haemodialysis.
69 Hydrochlorthiazid:
69 abortion or early resorption was noted at doses causing significant maternal toxicity, including mortality.
PSUR cyklus for Irbesartan Hydrochlorothiazide Winthrop er ioverenstemmelse med produktet COAPROVEL som krydshenvises til, indtil andet er specificeret.
The PSUR cycle of Irbesartan Hydrochlorothiazide Winthrop is aligned with the cross-referred product, COAPROVEL, until otherwise specified.
Irbesartan Hydrochlorothiazide Winthrop 150 mg/ 12, 5 mg tabletter irbesartan/ hydrochlorthiazid
Irbesartan Hydrochlorothiazide Winthrop 150 mg/ 12.5 mg tablets irbesartan/ hydrochlorothiazide
EU/ 1/ 06/ 377/ 001 14 tabletter EU/ 1/ 06/ 377/ 002 28 tabletter EU/ 1/ 06/ 377/ 003 56 tabletter EU/ 1/ 06/ 377/ 004 56 x 1 tabletter EU/ 1/ 06/ 377/ 005 98 tabletter
EU/ 1/ 06/ 377/ 001 14 tablets EU/ 1/ 06/ 377/ 002 28 tablets EU/ 1/ 06/ 377/ 003 56 tablets EU/ 1/ 06/ 377/ 004 56 x 1 tablets EU/ 1/ 06/ 377/ 005 98 tablets
Irbesartan Hydrochlorothiazide Winthrop 150mg/ 12, 5 mg
Irbesartan Hydrochlorothiazide Winthrop 150 mg/ 12.5 mg
Irbesartan Hydrochlorothiazide Winthrop 300 mg/ 12, 5 mg tabletter irbesartan/ hydrochlorthiazid
Irbesartan Hydrochlorothiazide Winthrop 300 mg/ 12.5 mg tablets irbesartan/ hydrochlorothiazide
EU/ 1/ 06/ 377/ 006 14 tabletter EU/ 1/ 06/ 377/ 007 28 tabletter EU/ 1/ 06/ 377/ 008 56 tabletter EU/ 1/ 06/ 377/ 009 56 x 1 tabletter EU/ 1/ 06/ 377/ 010 98 tabletter
EU/ 1/ 06/ 377/ 006 14 tablets EU/ 1/ 06/ 377/ 007 28 tablets EU/ 1/ 06/ 377/ 008 56 tablets EU/ 1/ 06/ 377/ 009 56 x 1 tablets EU/ 1/ 06/ 377/ 010 98 tablets
Irbesartan Hydrochlorothiazide Winthrop 300mg/ 12, 5 mg
Irbesartan Hydrochlorothiazide Winthrop 300 mg/ 12.5 mg
Irbesartan Hydrochlorothiazide Winthrop 150 mg/ 12, 5 mg filmovertrukne tabletter irbesartan/ hydrochlorthiazid
Irbesartan Hydrochlorothiazide Winthrop 150 mg/ 12.5 mg film-coated tablets irbesartan/ hydrochlorothiazide
EU/ 1/ 06/ 377/ 011 14 tabletter EU/ 1/ 06/ 377/ 012 28 tabletter EU/ 1/ 06/ 377/ 013 56 tabletter EU/ 1/ 06/ 377/ 014 56 x 1 tabletter EU/ 1/ 06/ 377/ 015 84 tabletter EU/ 1/ 06/ 377/ 016 98 tabletter
EU/ 1/ 06/ 377/ 011 14 tablets EU/ 1/ 06/ 377/ 012 28 tablets EU/ 1/ 06/ 377/ 013 56 tablets EU/ 1/ 06/ 377/ 014 56 x 1 tablets EU/ 1/ 06/ 377/ 015 84 tablets EU/ 1/ 06/ 377/ 016 98 tablets
Irbesartan Hydrochlorothiazide Winthrop 300 mg/ 12, 5 mg filmovertrukne tabletter irbesartan/ hydrochlorthiazid
Irbesartan Hydrochlorothiazide Winthrop 300 mg/ 12.5 mg film-coated tablets irbesartan/ hydrochlorothiazide
EU/ 1/ 06/ 377/ 017 14 tabletter EU/ 1/ 06/ 377/ 018 28 tabletter EU/ 1/ 06/ 377/ 019 56 tabletter EU/ 1/ 06/ 377/ 020 56 x 1 tabletter EU/ 1/ 06/ 377/ 021 84 tabletter EU/ 1/ 06/ 377/ 022 98 tabletter
EU/ 1/ 06/ 377/ 017 14 tablets EU/ 1/ 06/ 377/ 018 28 tablets EU/ 1/ 06/ 377/ 019 56 tablets EU/ 1/ 06/ 377/ 020 56 x 1 tablets EU/ 1/ 06/ 377/ 021 84 tablets EU/ 1/ 06/ 377/ 022 98 tablets
Irbesartan Hydrochlorothiazide Winthrop 300 mg/ 25 mg filmovertrukne tabletter irbesartan/ hydrochlorthiazid
Irbesartan Hydrochlorothiazide Winthrop 300 mg/ 25 mg film-coated tablets irbesartan/ hydrochlorothiazide
EU/ 1/ 06/ 377/ 023 14 tabletter EU/ 1/ 06/ 377/ 024 28 tabletter EU/ 1/ 06/ 377/ 025 56 tabletter EU/ 1/ 06/ 377/ 026 56 x 1 tabletter EU/ 1/ 06/ 377/ 027 84 tabletter EU/ 1/ 06/ 377/ 028 98 tabletter
EU/ 1/ 06/ 377/ 023 14 tablets EU/ 1/ 06/ 377/ 024 28 tablets EU/ 1/ 06/ 377/ 025 56 tablets EU/ 1/ 06/ 377/ 026 56 x 1 tablets EU/ 1/ 06/ 377/ 027 84 tablets EU/ 1/ 06/ 377/ 028 98 tablets
Irbesartan Hydrochlorothiazide Winthrop 300 mg/ 25 mg tabletter irbesartan/ hydrochlorthiazid
Irbesartan Hydrochlorothiazide Winthrop 300 mg/ 25 mg tablets irbesartan/ hydrochlorothiazide
INFORMATION TIL BRUGEREN Irbesartan Hydrochlorothiazide Winthrop 150 mg/ 12, 5 mg tabletter irbesartan/ hydrochlorthiazid
INFORMATION FOR THE USER Irbesartan Hydrochlorothiazide Winthrop 150 mg/ 12.5 mg tablets irbesartan/ hydrochlorothiazide
Spørg lægen eller på apoteket, hvis der er mere, du vil vide Lægen har ordineret Irbesartan Hydrochlorothiazide Winthrop til dig personligt.
If you have any further questions, ask your doctor or pharmacist.
Irbesartan Hydrochlorothiazide Winthrops virkning og hvad du skal bruge det til 2.
What Irbesartan Hydrochlorothiazide Winthrop is and what it is used for 2.
Det skal du vide, før du begynder at bruge Irbesartan Hydrochlorothiazide Winthrop 3.
Before you take Irbesartan Hydrochlorothiazide Winthrop 3.
Sådan skal du bruge Irbesartan Hydrochlorothiazide Winthrop 4.
How to take Irbesartan Hydrochlorothiazide Winthrop 4.
Sådan opbevarer du Irbesartan Hydrochlorothiazide Winthrop 6.
How to store Irbesartan Hydrochlorothiazide Winthrop 6.
IRBESARTAN HYDROCHLOROTHIAZIDE WINTHROPS VIRKNING OG HVAD DU SKAL BRUGE DET TIL
WHAT IRBESARTAN HYDROCHLOROTHIAZIDE WINTHROP IS AND WHAT IT IS USED FOR
Irbesartan Hydrochlorothiazide Winthrop indeholder en kombination af to aktive lægemidler, irbesartan og hydrochlorthiazid.
Irbesartan Hydrochlorothiazide Winthrop is a combination of two active substances, irbesartan and hydrochlorothiazide.
Når de to aktive stoffer i Irbesartan Hydrochlorothiazide Winthrop gives samtidigt, er deres effekt på blodtrykket større, end hvis de blev givet hver for sig.
The two active ingredients in Irbesartan Hydrochlorothiazide Winthrop work together to lower blood pressure further than if either was given alone.
Irbesartan Hydrochlorothiazide Winthrop bruges til at behandle forhøjet blodtryk (essentiel hypertension) når behandling med irbesartan eller hydrochlorthiazid hver for sig ikke har givet tilstrækkelig kontrol over blodtrykket.
Irbesartan Hydrochlorothiazide Winthrop is used in the treatment of high blood pressure (essential hypertension), when treatment with irbesartan or hydrochlorothiazide alone did not provide adequate control of your blood pressure.
DET SKAL DU VIDE, FØR DU BEGYNDER AT BRUGE IRBESARTAN HYDROCHLOROTHIAZIDE WINTHROP
BEFORE YOU TAKE IRBESARTAN HYDROCHLOROTHIAZIDE WINTHROP
Brug ikke Irbesartan Hydrochlorothiazide Winthrop: hvis du er overfølsom (allergisk) over for irbesartan, hydrochlorthiazid eller et af de andre indholdsstoffer i Irbesartan Hydrochlorothiazide Winthrop eller over for sulfapræparater. i de sidste 6 måneder af graviditeten, se afsnittet Graviditet og amning hvis du ammer hvis du har alvorlige lever - eller nyreproblemer (spørg lægen, hvis du er i tvivl) hvis du har problemer med urinproduktionen hvis du lider af en tilstand, der medfører konstant forhøjet calcium eller lavt kalium i blodet
Do not take Irbesartan Hydrochlorothiazide Winthrop if you are allergic (hypersensitive) to irbesartan and hydrochlorothiazide, or any of the other ingredients of Irbesartan Hydrochlorothiazide Winthrop or to sulfonamide-derived medicines during the last 6 months of pregnancy, see section Pregnancy and breastfeeding if you are breast-feeding if you have severe liver or kidney problems if you have difficulty in producing urine if you have a condition which is associated with persistently high calcium or low potassium levels in your blood
Irbesartan Hydrochlorothiazide Winthrop må ikke gives til børn (under 18 år).
Irbesartan Hydrochlorothiazide Winthrop should not be given to children and adolescents (< 18 years).
Vær ekstra forsigtig med at bruge Irbesartan Hydrochlorothiazide Winthrop: hvis du lider af hyppig opkastning eller diarré
Take special care with Irbesartan Hydrochlorothiazide Winthrop if you suffer from excessive vomiting or diarrhoea if you suffer from kidney problems, including kidney transplantation
Irbesartan Hydrochlorothiazide Winthrop bør ikke bruges tidligt i graviditeten og kan skade dit barn i de sidste 6 måneder af graviditeten, se afsnittet Graviditet og amning.
Irbesartan Hydrochlorothiazide Winthrop is not recommended in early pregnancy and may cause serious harm to your baby after 3 months of pregnancy, see section Pregnancy and breastfeeding.
Du skal også oplyse lægen om det: hvis du er på en saltfattig diæt hvis du har symptomer som voldsom tørst, mundtørhed, følelse af svaghed, sløvhed, muskelsmerter eller - kramper, kvalme, opkastning eller en voldsom hjertebanken, som kan være tegn på for kraftig effekt af hydrochlorthiazid (der er indeholdt i Irbesartan Hydrochlorothiazide Winthrop) hvis du skal opereres eller bedøves
You should also tell your doctor: if you are on a low-salt diet if you have signs such as abnormal thirst, dry mouth, general weakness, drowsiness, muscle pain or cramps, nausea, vomiting, or an abnormally fast heart beat which may indicate an excessive effect of hydrochlorothiazide (contained in Irbesartan Hydrochlorothiazide Winthrop) if you are to undergo any surgery or receive anaesthetics
Vanddrivende stoffer som hydrochlorthiazider, som findes i Irbesartan Hydrochlorothiazide Winthrop, kan påvirke anden medicin.
Diuretic agents such as the hydrochlorothiazide contained in Irbesartan Hydrochlorothiazide Winthrop may interact with other medicines.
Tag ikke medicin der indeholder lithium samtidig med at du tager Irbesartan Hydrochlorothiazide Winthrop uden grundig vejledning fra lægen.
Preparations containing lithium should not be taken with Irbesartan Hydrochlorothiazide Winthrop without close supervision by your doctor.
Hvis du tager nogle af følgende medikamenter anbefales det, at du får foretaget kontrolmålinger (for eksempel blodprøver): kaliumtilskud, kaliumholdige salterstatninger eller anden kalium- besparende medicin, andre vanddrivende midler, visse afføringsmidler, medicin til behandling af urinsyregigt, terapeutisk vitamin D- tilskud, medicin til kontrol af hjerterytmen eller medicin for sukkersyge (tabletter eller insulin).
Special precautionary measures (e. g. blood tests) may be appropriate if you take potassium supplements, potassium- containing salt substitutes or potassium sparing medicines, other diuretics (water tablets), some laxatives, medicines for the treatment of gout, therapeutic vitamin D supplements, medicines to control heart rhythm or for diabetes (oral agents or insulins).
Brug af Irbesartan Hydrochlorothiazide Winthrop sammen med mad og drikke Irbesartan Hydrochlorothiazide Winthrop kan tages med og uden mad.
Taking Irbesartan Hydrochlorothiazide Winthrop with food and drink Irbesartan Hydrochlorothiazide Winthrop can be taken with or without food.
Din læge vil sædvanligvis anbefale, at du tager et andet lægemiddel end Irbesartan Hydrochlorothiazide Winthrop, da Irbesartan Hydrochlorothiazide Winthrop ikke bør tages i begyndelsen af graviditeten, og kan skade dit barn alvorligt, hvis det bruges i de sidste 6 måneder af graviditeten.
Usually, your doctor will advise you to take another medicine instead of Irbesartan Hydrochlorothiazide Winthrop, as Irbesartan Hydrochlorothiazide Winthrop is not recommended in early pregnancy, and may cause serious harm to your baby if it is used after 3 months of pregnancy.
Før du bliver gravid bør Irbesartan Hydrochlorothiazide Winthrop sædvanligvis erstattes af en anden slags blodtrykssænkende medicin.
Appropriate antihypertensive drug must usually replace Irbesartan Hydrochlorothiazide Winthrop before starting a pregnancy.
Din læge vil normalt beslutte, at du skal stoppe med at tage Irbesartan Hydrochlorothiazide Winthrop, så snart du ved, at du er gravid.
Your doctor will normally advise you to stop taking Irbesartan Hydrochlorothiazide Winthrop as soon as you know you are pregnant.
Hvis du bliver gravid, mens du er i behandling med Irbesartan Hydrochlorothiazide Winthrop, skal du straks kontakte din læge.
If you become pregnant during therapy with Irbesartan Hydrochlorothiazide Winthrop, please inform and see your doctor without delay.
Irbesartan Hydrochlorothiazide Winthrop påvirker sandsynligvis ikke din evne til at køre bil eller betjene maskiner.
Irbesartan Hydrochlorothiazide Winthrop is unlikely to affect your ability to drive or use machines.
93 Vigtig information om nogle af de øvrige indholdsstoffer i Irbesartan Hydrochlorothiazide Winthrop Irbesartan Hydrochlorothiazide Winthrop indeholder lactosemonohydrat (se ” Yderligere oplysninger ”) Hvis lægen har fortalt dig, at du er intolerant over for bestemte sukkerarter, bør du kontakte lægen inden du bruger denne medicin.
If you have been told by your doctor that you have an intolerance to some sugars (e. g. lactose), contact your doctor before taking this medicine.
SÅDAN SKAL DU BRUGE IRBESARTAN HYDROCHLOROTHIAZIDE WINTHROP
HOW TO TAKE IRBESARTAN HYDROCHLOROTHIAZIDE WINTHROP
Tag altid Irbesartan Hydrochlorothiazide Winthrop nøjagtigt efter lægens anvisning.
Always take Irbesartan Hydrochlorothiazide Winthrop exactly as your doctor has told you.
Lægen vil sandsynligvis starte behandling med Irbesartan Hydrochlorothiazide Winthrop, hvis den tidligere behandling for forhøjet blodtryk ikke har haft tilstrækkelig effekt.
Irbesartan Hydrochlorothiazide Winthrop will usually be prescribed by your doctor when your previous treatment for high blood pressure did not provide appropriate blood pressure reduction.
Lægen vil forklare, hvordan du skifter fra den tidligere behandling til behandling med Irbesartan Hydrochlorothiazide Winthrop.
Your doctor will instruct you how to switch from the previous treatment to Irbesartan Hydrochlorothiazide Winthrop.
Den sædvanlige dosis af Irbesartan Hydrochlorothiazide Winthrop er en eller to tabletter dagligt.
The usual dose of Irbesartan Hydrochlorothiazide Winthrop is one or two tablets a day.
Du kan tage Irbesartan Hydrochlorothiazide Winthrop med eller uden mad.
You can take Irbesartan Hydrochlorothiazide Winthrop with or without food.
Det er vigtigt, at du fortsætter med at tage Irbesartan Hydrochlorothiazide Winthrop, indtil lægen siger du kan stoppe.
It is important that you continue to take Irbesartan Hydrochlorothiazide Winthrop until your doctor tells you otherwise.
Hvis du har taget for meget Irbesartan Hydrochlorothiazide Winthrop Hvis du ved et uheld har taget for mange tabletter, eller hvis et barn har taget nogle tabletter, skal du omgående kontakte lægen.
If you take more Irbesartan Hydrochlorothiazide Winthrop than you should If you accidentally take too many tablets, or a child swallows some, contact your doctor immediately.
Hvis du har glemt at tage Irbesartan Hydrochlorothiazide Winthrop Hvis du har glemt at tage en dosis, skal du blot tage den næste til sædvanlig tid.
If you forget to take Irbesartan Hydrochlorothiazide Winthrop If you accidentally miss a daily dose, just take the next dose as normal.
Irbesartan Hydrochlorothiazide Winthrop kan som al anden medicin give bivirkninger, men ikke alle får bivirkninger.
Like all medicines, Irbesartan Hydrochlorothiazide Winthrop can cause side effects, although not everybody gets them.
Følgende bivirkninger er indberettet i medicinske forsøg med patienter, som fik behandling med Irbesartan Hydrochlorothiazide Winthrop:
Side effects reported in clinical studies for patients treated with Irbesartan Hydrochlorothiazide Winthrop were:
94 Følgende bivirkninger er lejlighedsvist indberettet efter markedsføring af Irbesartan Hydrochlorothiazide Winthrop: hovedpine, ringen for ørerne, hoste, smagsforstyrrelser, forstoppelse, led - og muskelsmerter, leversygdom og nedsat nyrefunktion.
Occasional side effects reported since the marketing of Irbesartan Hydrochlorothiazide Winthrop are: headache, ringing in the ears, cough, taste disturbance, indigestion, pain in joints and muscles, liver function abnormal and impaired renal function.
Som ved anden medicin af samme type, er der rapporteret om sjældne tilfælde af allergiske hudreaktioner (udslæt, nældefeber) samt opsvulmet ansigt, læber og/ eller tunge hos patienter behandlet med irbesartan.
If you think
Hvis du mener, at du er ved at få en sådan reaktion, eller hvis du får åndenød, skal du stoppe med at tage Irbesartan Hydrochlorothiazide Winthrop og straks søge lægehjælp.
94 you are developing such a reaction or get short of breath stop taking Irbesartan Hydrochlorothiazide Winthrop and seek immediate medical attention.
Det andet aktive stof i Irbesartan Hydrochlorothiazide Winthrop (hydrochlorthiazid) har i sjældne tilfælde været forbundet med mere alvorlige bivirkninger.
The other component of Irbesartan Hydrochlorothiazide Winthrop (hydrochlorothiazide) has been associated rarely with other more serious side effects mainly affecting the blood, the skin or the kidneys.
Selvom dette ikke er observeret med Irbesartan Hydrochlorothiazide Winthrop, kan det ikke udelukkes.
While this was not observed with Irbesartan Hydrochlorothiazide Winthrop, occurrence of such side effects cannot be excluded.
SÅDAN OPBEVARER DU IRBESARTAN HYDROCHLOROTHIAZIDE WINTHROP
HOW TO STORE IRBESARTAN HYDROCHLOROTHIAZIDE WINTHROP